Keywords
Last Name
Institution

Funding Agency: NIH/Nat. Cancer Institute
Title: Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML
Award Number: 5 R01 CA194094-04
Start Date: 2016-09-01


Collapse Overview 
Collapse researcher role of